Navigation Links
NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
Date:2/28/2013

LAWRENCE, Mass., Feb. 28, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2012, that includes revenue above the top end of its guidance range.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Revenue for the full-year 2012 increased 11 percent to $242.1 million, compared with revenue of $217.3 million for the full-year 2011.  Revenue for the fourth quarter of 2012 increased 14 percent to a record $65.0 million compared with revenue of $57.0 million for the fourth quarter of 2011.  The increase in both periods was led by the Company's solid performance in the Home market as a result of growing adoption of more frequent home hemodialysis with the NxStage System One.

Consistent with the Company's guidance, Home delivered 14 percent annual growth, with revenue increasing to $123.6 million for the full-year 2012 compared with revenue of $108.5 million for the full-year 2011.  Home revenue increased to $31.4 million in the fourth quarter of 2012 compared with revenue of $28.2 million in the fourth quarter of 2011, representing an 11 percent increase.  As expected, growth in the Home for the fourth quarter of 2012 was negatively impacted by the timing of capital equipment purchases from international distributors in the quarter.

Critical Care delivered 13 percent annual growth, with revenue increasing to $39.5 million for the full-year 2012 compared with revenue of $35.0 million for the full-year 2011.  Revenue in Critical Care increased to $11.3 million in the fourth quarter of 2012, compared with revenue of $9.8 million in the fourth quarter of 2011, represen
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
2. Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant
3. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
4. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
5. NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. NxStage Patient and Advocate Brian Hess Receives Prestigious Honor from American Association of Kidney Patients
7. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
8. NxStage Names Todd M. Snell Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs
9. NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012
10. NxStage Announces Fourth Quarter 2012 Investor Conference Schedule
11. Robert Funari Joins NxStage Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BioPharmX Corporation (NYSE MKT: BPMX) a Silicon Valley-based ... chief executive officer and co-founder of BioPharmX, will present at ... place, September 8-10, 2015 at The St. Regis Hotel, ... scheduled to present on September 10 from 2:10 to 2:35 ... A live webcast of the presentation will be ...
(Date:9/2/2015)... 2, 2015 Tumultuous market conditions – including ... care M&A activity – have led more than half ... pharmaceutical sales reps. This marks the first time that ... the halfway point, according to the spring 2015 ... ZS . AccessMonitor™ aggregates ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics (Kastle), ... commercializing pharmaceuticals for diseases with high unmet medical ... executives to key commercial operating positions. ... President, Commercial; Sean was previously Global Marketing Director ... appointed as Director, Commercial Strategy and Analytics; Nick ...
Breaking Medicine Technology:Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
... 7, 2011 Akorn, Inc. (NASDAQ: AKRX ... 2011, to discuss third quarter 2011 results followed by a ... day before the market opens. Subject: , Akorn, Inc. ... 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , (888) ...
... PARSIPPANY, N.J., Oct. 7, 2011 Watson Pharmaceuticals, Inc. ... subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated ... Drug Administration (FDA) seeking approval to market Morphine Sulfate ... mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg, and ...
Cached Medicine Technology:Watson Confirms EMBEDA(R) Patent Challenge 2Watson Confirms EMBEDA(R) Patent Challenge 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... , ... September 01, 2015 , ... For many men, the first thing they notice ... were often forced to wear a looser fitting shirt with a collar that doesn’t close ... a finger between their collar and skin all day because it’s uncomfortable. Now men ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... 2015 , ... The Journal of Pain Research has published the ... , As corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic ... to better understand how migraine headaches impact the lives of migraineurs. We asked migraineurs ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... According ... Medical Association, individuals with type 2 diabetes that participated in a three year study ... three years down the line if they elected weight loss surgery at the onset ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... 19 Delta Dental of Illinois has ... of Illinois at Chicago,College of Dentistry to ... renovations are complete, the clinic will be ... Dentistry Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... Ind., Dec. 19 Zimmer Holdings, Inc.,(NYSE: ZMH ... announced,today it will be participating in the 26th Annual ... at 12:00 p.m. Eastern Time., A live webcast ... website at http://investor.zimmer.com . The webcast will,be archived ...
... takes the first step in offering nationwide services, ... announced its plan to expand its services to four ... Area during,the summer of 2007, and is now expanding ... The company hosts a website where healthcare,providers and patients ...
... (MGH) researchers have identified a new molecular pathway that ... This early-stage kidney disease affects 100 million people around ... the kidneys filtering structures. Blocking this pathway could ... slow the process of kidney failure. The research ...
... Device might aid in the detection and monitoring of cancer, ... U.S. team has developed a microchip device that can detect ... has a silicon chip with about 80,000 microscopic posts. Each ... expressed by most solid tumors. The device is able to ...
... Massachusetts General Hospital (MGH) Biomicroelectromechanical Systems (BioMEMS) Resource Center ... device that can isolate, enumerate and analyze circulating tumor ... viable cells from solid tumors carried in the bloodstream ... Because of their rarity and fragility, it has ...
Cached Medicine News:Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Microchip Spots Stray Tumor Cells in the Bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 3
... Osteopal V is a low viscosity bone ... in vertebroplasty. The bone cement is injected ... purposes. Osteopal V is used for the ... of zirconium dioxide is included in the ...
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... a comprehensive platform for standard neurosurgical ... to plan the optimal surgical path ... Combined with unique features such as ... planning tool, Neurosight becomes a very ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with our displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless...
Medicine Products: